Minimal impact

legal court gavel drugs pills
Mixed findings for benefits of tamper-resistant oxycodone The introduction of tamper-resistant oxycodone formulations in Australia in early 2014 has led to little change in the levels of population-level opioid use or harm, new research has revealed. Time-series analyses of opioid sales data and collected health datasets have shown that controlled-release oxycodone reduced tampering with pharmaceutical

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Mental health care "grossly underfunded": AMA
Next Better access